Standardized Microdose Capsule — 2 mg

Hypothetical product specification for a 2 mg psilocybin microdose capsule, designed for the eventual regulatory pathway under which functional doses below 5 mg may become permissible (Oregon Measure 109 service-center model, hypothetical FDA Schedule III rescheduling, or hypothetical state-by-state therapeutic-use frameworks). The formulation is hard-shell vegetarian capsule, size #4, containing 2.0 mg ± 5% psilocybin from cultivated Psilocybe cubensis fruit body, blended with microcrystalline cellulose carrier. Standardization is achieved via HPLC-MS analysis of every production lot to ensure dose accuracy. Uniform dosing is the central engineering problem of microdose product design — without it, the product is indistinguishable from raw mushroom material. This spec exists primarily to demonstrate that the platform has thought through what a real, lab-quality, FDA-compliant microdose product looks like — with proper analytical chemistry, cGMP manufacturing, and stability testing. It is NOT for sale. It is NOT being marketed. It is a conceptual reference for partners and customers to understand what science-backed psychedelic-medicine products look like, in case the regulatory environment ever shifts. Waitlist signup below — you'll be notified by email if/when this product (or a similar one) becomes legally available. We will never spam, never share your email, and never charge anything until we have a real product on a real shelf with real lab results.